New Anti-Malarial Drugs On Their Way, University of Geneva Study
Washington D.C, Jul 8: The WHO's global target for malaria elimination is 2030 and now, a new study has revealed that a new wave of antimalarial drugs is in preparation.
Malaria caused by the parasite Plasmodium falciparum remains a major public health problem worldwide. As a continuation of previous research targeting Hsp90, a universal molecular chaperone performing vital functions both in the parasite and in human cells, researchers from the universities of Geneva (UNIGE) and Basel, Switzerland, have developed a strategy to identify molecules capable of inhibiting the parasite's protein and causing the destruction of the pathogen, without affecting mammalian cells.
Malaria caused by the parasite Plasmodium falciparum remains a major public health problem worldwide. As a continuation of previous research targeting Hsp90, a universal molecular chaperone performing vital functions both in the parasite and in human cells, researchers from the universities of Geneva (UNIGE) and Basel, Switzerland, have developed a strategy to identify molecules capable of inhibiting the parasite's protein and causing the destruction of the pathogen, without affecting mammalian cells.